This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Retrograde Intrarenal Stone Surgery - A Method of Treating the ESWL Resistant Kidney Stone

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2007 by Fredericia Hosptial.
Recruitment status was:  Active, not recruiting
Information provided by:
Fredericia Hosptial Identifier:
First received: May 8, 2006
Last updated: January 29, 2007
Last verified: January 2007
Is it possible to decrease the intrarenal pressure in the kidney during endoscopic management of kidney stone by topical administration of drugs? In order to secure fewer complications in ureteroscopic operations the pharmacological agent isoproterenol is tested on pigs and human to determine its potential of lowering intrarenal pressure.

Condition Intervention Phase
Kidney Stone Ureteroscopy Drug: Isoproterenol Phase 2

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: RIRS - A Method of Treating the ESWL Resistant Kidney Stone

Resource links provided by NLM:

Further study details as provided by Fredericia Hosptial:

Primary Outcome Measures:
  • Renal pelvic pressure

Secondary Outcome Measures:
  • Blood pressure
  • Pulse

Estimated Enrollment: 10
Study Start Date: June 2006
Estimated Study Completion Date: February 2007

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Indication for RIRS procedure
  • Age > 18 years
  • Normotensive
  • Capable of understanding information given

Exclusion Criteria:

  • Previous myocardiac infarct
  • Daily use of alpha- og beta- blocking medicine og calcium antagonists
  • Use of NSAID the last 2 days
  • Stone in the ureter
  • Declared
  • Known malignant disease in urinary tract
  • Bladder disease
  • Nephrostomies inserted
  • JJ-catheters inserted
  • Prisoners
  • Pregnant
  • Nursing mothers
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00323843

Dpt. of Urology
Fredericia, Vejle Council, Denmark, 7000
Sponsors and Collaborators
Fredericia Hosptial
Principal Investigator: Helene U Jung Fredericia Hospital, Dpt. of Urology
  More Information Identifier: NCT00323843     History of Changes
Other Study ID Numbers: 2005-005972-34
Study First Received: May 8, 2006
Last Updated: January 29, 2007

Keywords provided by Fredericia Hosptial:
Kidney stone
renal pelvic pressure

Additional relevant MeSH terms:
Kidney Calculi
Pathological Conditions, Anatomical
Kidney Diseases
Urologic Diseases
Urinary Calculi
Adrenergic beta-Agonists
Adrenergic Agonists
Adrenergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Bronchodilator Agents
Autonomic Agents
Peripheral Nervous System Agents
Anti-Asthmatic Agents
Respiratory System Agents
Cardiotonic Agents
Protective Agents processed this record on September 21, 2017